Projects funded by the NCN

Chemical effects in targeted drug delivery: The roles of anticancer drugs, carriers and conjugates on biomimetic membran...

Call: SONATA 12 , Panel: ST4

Principal investigator: dr Dorota Maria Nieciecka

Uniwersytet Warszawski, Wydział Chemii

CRON diet as an alternative for athlets finishing their sporting carier.

Call: OPUS 1 , Panel: NZ7

Principal investigator: prof. Ewa Stachowska

Pomorski Uniwersytet Medyczny w Szczecinie, Wydział Nauk o Zdrowiu

Evaluation of photoinactivation potential in the eradication of Streptococcus agalactiae carrier-state in the urogenital...

Call: OPUS 12 , Panel: NZ7

Principal investigator: dr hab. Mariusz Stanisław Grinholc

Uniwersytet Gdański, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

Smart nanoparticles based on polylactides copolymers and their stereocomplexes as potential delivery systems of biologic...

Call: SONATA 12 , Panel: ST5

Principal investigator: dr Marek Brzeziński

Centrum Badań Molekularnych i Makromolekularnych PAN

Mechanism of incorporation of lipid liquid crystalline drug carriers - cubosomes and and hexosomes into lipid membranes

Call: OPUS 12 , Panel: ST4

Principal investigator: prof. Renata Bilewicz

Uniwersytet Warszawski, Wydział Chemii

Endocytosis-stimulating antibodies against multidrug transporters as drug carriers

Call: OPUS 10 , Panel: NZ7

Principal investigator: dr hab. Łukasz Pułaski

Instytut Biologii Medycznej PAN

INNOvative antiSEPTic agents for a therapy with a broad spectrum of action

Call: OPUS 10 , Panel: NZ7

Principal investigator: dr Sebastian Kraszewski

Politechnika Wrocławska

Polymer-based nanostructures modified with biologically active substances for selective accumulation and release of drug...

Call: PRELUDIUM 10 , Panel: ST5

Principal investigator: Wioletta Sylwia Liwińska

Uniwersytet Warszawski, Wydział Chemii

Synthesis, physicochemical and biological properties of conjugates of cellulose derivatives wih methotrexate.

Call: PRELUDIUM 9 , Panel: NZ7

Principal investigator: dr Jarosław Łukasz Ciekot

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk